Intervention not reported
TXA given intravenously and intra‐articularly at a total dose of 2 g intraoperatively · individuals undergoing planned hip or knee replacement surgery Interventions: antifibrinolytics (tranexamic acid, aprotinin or…
1 finding from 1 review
no estimate extracted
2 participants
Moderate
Intervention not reported
TXA given intravenously and orally at a total dose of greater than 3 g pre‐incision and postoperatively · individuals undergoing planned hip or knee replacement surgery Interventions: antifibrinolytics (tranexamic acid, aprotinin or…
1 finding from 1 review
no estimate extracted
3 participants
Low
Intervention not reported
TXA given intravenously at a total dose of 1 g pre‐incision and postoperatively · individuals undergoing planned hip or knee replacement surgery Interventions: antifibrinolytics (tranexamic acid, aprotinin or…
1 finding from 1 review
no estimate extracted
1 participants
Low
Intervention not reported
TXA given intravenously and intra‐articularly at a total dose of greater than 3 g pre‐incision, intraoperatively and postoperatively · individuals undergoing planned hip or knee replacement surgery Interventions: antifibrinolytics (tranexamic acid, aprotinin or…
1 finding from 1 review
no estimate extracted
3 participants
Low
Intervention not reported
Presence of PHN 6 months after the onset of acute herpetic rashClinical manifestation · people with acute herpes zoster (within 7 days of onset of rash)
It is very uncertain whether the intervention changes presence of PHN 6 months after the onset of acute herpetic… (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse eventsClinical manifestation and laboratory examination · people with acute herpes zoster (within 7 days of onset of rash)
It is very uncertain whether the intervention changes serious adverse eventsClinical manifestation and laboratory… (very low certainty).
1 finding from 1 review
Intervention not reported
Non‐serious adverse eventsClinical manifestation and laboratory examination · people with acute herpes zoster (within 7 days of onset of rash)
The intervention showed no clear difference in non‐serious adverse eventsClinical manifestation and laboratory… (low certainty).
1 finding from 1 review
Time required for successful intubation · neonates (0 to 28 days of age) who needed tracheal intubation
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Number of intubation attempts · neonates (0 to 28 days of age) who needed tracheal intubation
1 finding from 1 review
no estimate extracted
Studies not reported
Low
First‐attempt success rate · neonates (0 to 28 days of age) who needed tracheal intubation
Videolaryngoscopy may leads to higher success rate at first attempt compared with conventional direct laryngoscopy (low certainty).
1 finding from 1 review
RR 1.24 [1.13, 1.37]
Studies not reported
Low
Non‐airway‐related adverse effects: desaturation or bradycardia episodes, or both · neonates (0 to 28 days of age) who needed tracheal intubation
It is very uncertain whether videolaryngoscopy changes non‐airway‐related adverse effects: desaturation or bradycardia… compared with conventional direct laryngoscopy (very low certainty).
1 finding from 1 review
RR 0.94 [0.38, 2.3]
Studies not reported
Very low
Non‐airway‐related adverse effects: lowest saturations during intubation · neonates (0 to 28 days of age) who needed tracheal intubation
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Airway‐related adverse effects: airway trauma · neonates (0 to 28 days of age) who needed tracheal intubation
Videolaryngoscopy probably leads to lower airway‐related adverse effects: airway trauma compared with conventional direct laryngoscopy (moderate certainty).
1 finding from 1 review
RR 0.21 [0.05, 0.79]
Studies not reported
Moderate
MACE · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in MACE compared with aspirin (low certainty).
1 finding from 1 review
Death · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in death compared with aspirin (low certainty).
1 finding from 1 review
All major occlusive vascular events · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intracerebral haemorrhage (ICH) · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
Summary of findings table ‐ Cilostazol showed no clear difference in intracerebral haemorrhage (ICH) compared with aspirin (low certainty).
1 finding from 1 review
Functional status ‐ not reported · adults within 180 days of non‐cardioembolic ischaemic stroke or transient ischaemic attack and a clinical history of prior intracerebral…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · preterm infants with apnea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurodevelopmental outcomes · preterm infants with apnea
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found